Printer's No. PN1741
See other bills
under the
same topic PRINTER'S NO. 1741 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.325 Session of 2026 INTRODUCED BY BROOKS, LANGERHOLC, L. WILLIAMS, PHILLIPS-HILL, MASTRIANO, HAYWOOD, MARTIN, CULVER, VOGEL, KANE, J. WARD, COSTA AND COMITTA, MAY 21, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, MAY 21, 2026 A RESOLUTIONDesignating the month of May 2026 as "Lyme Disease and Tick-Borne Illness Awareness Month" in Pennsylvania.WHEREAS, Lyme disease is a bacterial infection caused by spirochete Borrelia burgdorferi and is transmitted to humans through the bite of an infected Ixodes scapularis tick, also known as a blacklegged tick or deer tick; andWHEREAS, Lyme disease and tick-borne illnesses such as babesiosis, bartonellosis, anaplasmosis, Rocky Mountain spotted fever, ehrlichiosis, Heartland virus, Powassan virus disease, Borrelia miyamotoi, alpha-gal allergy syndrome and others pose a serious threat to the health and quality of life of many residents of this Commonwealth; andWHEREAS, Early stage symptoms of Lyme disease can include erythema migrans, a red, oval or round rash, fever, chills, headache, muscle and joint pain and swollen lymph nodes; andWHEREAS, Later stage symptoms of Lyme disease can include severe headaches and neck stiffness, additional erythema 1234567891011121314151617 migrans, arthritis with severe joint pain and swelling, particularly in the knees and other large joints, facial palsy, intermittent pain in tendons, muscles, joints and bones, heart palpitations or an irregular heartbeat, episodes of dizziness or shortness of breath, inflammation of the brain and spinal cord, nerve pain, shooting pains, numbness or tingling in the hands or feet and problems with short-term memory; andWHEREAS, According to the Centers for Disease Control and Prevention, Lyme disease is the most common vector-borne disease in the United States and is one of the most common reportable infectious diseases in this Commonwealth; andWHEREAS, In 2025, the Department of Health recorded 18,747 lab-confirmed cases of Lyme disease, a significant increase over 16,624 lab-informed cases in 2024; andWHEREAS, The Centers for Disease Control and Prevention estimate underreporting by a factor of 10 and project occurrence rates, more accurately, near 187,000; andWHEREAS, Approximately 20% of Lyme disease cases will cause long-term chronic symptoms; andWHEREAS, Approximately one in four cases of Lyme disease occur in children, and children five to nine years of age are at the greatest risk for contracting Lyme disease; andWHEREAS, In 2022, 54.9% of ticks tested in this Commonwealth were infected with at least one tick-borne pathogen, including Lyme disease, anaplasmosis, babesiosis, hard tick relapsing fever and Powassan virus; andWHEREAS, Also in 2022, Pennsylvania reported its first human case of Heartland virus, an arbovirus transmitted by the lone star tick; andWHEREAS, In 2024, Pennsylvania reported 1,071 cases of 20260SR0325PN1741 - 2 - 123456789101112131415161718192021222324252627282930 anaplasmosis, a bacterial disease transmitted by deer ticks, which is on the rise as cases have doubled nearly every year for the past five years and are now found in almost every county in Pennsylvania; andWHEREAS, Results from Department of Environmental Protection tick studies conducted during 2019 through 2024 found additional evidence of Powassan virus disease in multiple counties; andWHEREAS, Additionally, Department of Environmental Protection tick studies conducted during 2023 through 2024 found that approximately 1.4% of adult Ixodes scapularis ticks in Pennsylvania were infected with Borrelia miyamotoi, which was found in ticks in 34 Pennsylvania counties and causes hard tick relapsing fever in humans; andWHEREAS, Beginning in 2026, the Department of Health requested positive reports of alpha-gal allergy syndrome from testing laboratories, which will be furnished voluntarily because alpha-gal allergy syndrome is not a reportable condition in Pennsylvania; andWHEREAS, Alpha-gal allergy syndrome is an allergy to mammalian meat products associated with the bite of a lone star tick, which is present in Pennsylvania, although populations are low at this time; andWHEREAS, Positive alpha-gal allergy syndrome reports from laboratories that voluntarily provide positive reports show that more than 300 persons per year test positive for alpha-gal allergy syndrome and that persons with alpha-gal allergy syndrome may experience symptoms ranging from mild gastrointestinal irritation to anaphylaxis requiring hospitalization after consuming mammalian meat products; andWHEREAS, The blacklegged tick has been found in all 67 20260SR0325PN1741 - 3 - 123456789101112131415161718192021222324252627282930 counties in this Commonwealth, verifying that every resident from Erie to Philadelphia must take precautions to prevent the spread of Lyme disease and tick-borne illnesses; andWHEREAS, Residents of this Commonwealth can greatly reduce their chance of tick bites and pathogen transmission during the spring season by taking proper precautions while engaged in outdoor activities, making frequent tick checks and removing and disposing of ticks promptly and properly; andWHEREAS, The Tick Research Lab of Pennsylvania, an East Stroudsburg University-affiliated lab, is dedicated to providing free, fast, highly rated laboratory-quality tick testing to residents of this Commonwealth for Lyme disease, anaplasmosis, babesiosis, ehrlichiosis and Rocky Mountain spotted fever; andWHEREAS, Residents of this Commonwealth should be aware of early, disseminated and late or persistent symptoms, and that early clinical diagnosis and appropriate treatment of these tick-borne diseases and illnesses can greatly reduce the risks of continued, diverse and chronic symptoms that can affect every system and organ of the human body and often every aspect of an individual's life; andWHEREAS, As Lyme disease is endemic, the Department of Health wants to ensure that all residents of this Commonwealth have access to testing, and the Bureau of Laboratories has the capacity to perform Lyme disease testing for all uninsured or underinsured residents, but residents should also be informed that a negative Lyme disease test cannot rule out Lyme disease; andWHEREAS, "Lyme Disease and Tick-Borne Illness Awareness Month" provides an opportunity to focus on these significant and complex diseases, through dissemination of information on 20260SR0325PN1741 - 4 - 123456789101112131415161718192021222324252627282930 prevention and personal protection, raising public awareness of the causes, effects, potential severity, diagnostic challenges and treatment options of Lyme disease and underscoring important education efforts surrounding Lyme disease and other tick-borne illnesses; therefore be itRESOLVED, That the Senate designate the month of May 2026 as "Lyme Disease and Tick-Borne Illness Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the Senate continue efforts to benefit the overall health and quality of life of the residents of this Commonwealth by increasing awareness of the threat of tick bites and the potential seriousness of Lyme disease and other tick-borne illnesses.20260SR0325PN1741 - 5 - 12345678910111213
under the
same topic PRINTER'S NO. 1741 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.325 Session of 2026 INTRODUCED BY BROOKS, LANGERHOLC, L. WILLIAMS, PHILLIPS-HILL, MASTRIANO, HAYWOOD, MARTIN, CULVER, VOGEL, KANE, J. WARD, COSTA AND COMITTA, MAY 21, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, MAY 21, 2026 A RESOLUTIONDesignating the month of May 2026 as "Lyme Disease and Tick-Borne Illness Awareness Month" in Pennsylvania.WHEREAS, Lyme disease is a bacterial infection caused by spirochete Borrelia burgdorferi and is transmitted to humans through the bite of an infected Ixodes scapularis tick, also known as a blacklegged tick or deer tick; andWHEREAS, Lyme disease and tick-borne illnesses such as babesiosis, bartonellosis, anaplasmosis, Rocky Mountain spotted fever, ehrlichiosis, Heartland virus, Powassan virus disease, Borrelia miyamotoi, alpha-gal allergy syndrome and others pose a serious threat to the health and quality of life of many residents of this Commonwealth; andWHEREAS, Early stage symptoms of Lyme disease can include erythema migrans, a red, oval or round rash, fever, chills, headache, muscle and joint pain and swollen lymph nodes; andWHEREAS, Later stage symptoms of Lyme disease can include severe headaches and neck stiffness, additional erythema 1234567891011121314151617 migrans, arthritis with severe joint pain and swelling, particularly in the knees and other large joints, facial palsy, intermittent pain in tendons, muscles, joints and bones, heart palpitations or an irregular heartbeat, episodes of dizziness or shortness of breath, inflammation of the brain and spinal cord, nerve pain, shooting pains, numbness or tingling in the hands or feet and problems with short-term memory; andWHEREAS, According to the Centers for Disease Control and Prevention, Lyme disease is the most common vector-borne disease in the United States and is one of the most common reportable infectious diseases in this Commonwealth; andWHEREAS, In 2025, the Department of Health recorded 18,747 lab-confirmed cases of Lyme disease, a significant increase over 16,624 lab-informed cases in 2024; andWHEREAS, The Centers for Disease Control and Prevention estimate underreporting by a factor of 10 and project occurrence rates, more accurately, near 187,000; andWHEREAS, Approximately 20% of Lyme disease cases will cause long-term chronic symptoms; andWHEREAS, Approximately one in four cases of Lyme disease occur in children, and children five to nine years of age are at the greatest risk for contracting Lyme disease; andWHEREAS, In 2022, 54.9% of ticks tested in this Commonwealth were infected with at least one tick-borne pathogen, including Lyme disease, anaplasmosis, babesiosis, hard tick relapsing fever and Powassan virus; andWHEREAS, Also in 2022, Pennsylvania reported its first human case of Heartland virus, an arbovirus transmitted by the lone star tick; andWHEREAS, In 2024, Pennsylvania reported 1,071 cases of 20260SR0325PN1741 - 2 - 123456789101112131415161718192021222324252627282930 anaplasmosis, a bacterial disease transmitted by deer ticks, which is on the rise as cases have doubled nearly every year for the past five years and are now found in almost every county in Pennsylvania; andWHEREAS, Results from Department of Environmental Protection tick studies conducted during 2019 through 2024 found additional evidence of Powassan virus disease in multiple counties; andWHEREAS, Additionally, Department of Environmental Protection tick studies conducted during 2023 through 2024 found that approximately 1.4% of adult Ixodes scapularis ticks in Pennsylvania were infected with Borrelia miyamotoi, which was found in ticks in 34 Pennsylvania counties and causes hard tick relapsing fever in humans; andWHEREAS, Beginning in 2026, the Department of Health requested positive reports of alpha-gal allergy syndrome from testing laboratories, which will be furnished voluntarily because alpha-gal allergy syndrome is not a reportable condition in Pennsylvania; andWHEREAS, Alpha-gal allergy syndrome is an allergy to mammalian meat products associated with the bite of a lone star tick, which is present in Pennsylvania, although populations are low at this time; andWHEREAS, Positive alpha-gal allergy syndrome reports from laboratories that voluntarily provide positive reports show that more than 300 persons per year test positive for alpha-gal allergy syndrome and that persons with alpha-gal allergy syndrome may experience symptoms ranging from mild gastrointestinal irritation to anaphylaxis requiring hospitalization after consuming mammalian meat products; andWHEREAS, The blacklegged tick has been found in all 67 20260SR0325PN1741 - 3 - 123456789101112131415161718192021222324252627282930 counties in this Commonwealth, verifying that every resident from Erie to Philadelphia must take precautions to prevent the spread of Lyme disease and tick-borne illnesses; andWHEREAS, Residents of this Commonwealth can greatly reduce their chance of tick bites and pathogen transmission during the spring season by taking proper precautions while engaged in outdoor activities, making frequent tick checks and removing and disposing of ticks promptly and properly; andWHEREAS, The Tick Research Lab of Pennsylvania, an East Stroudsburg University-affiliated lab, is dedicated to providing free, fast, highly rated laboratory-quality tick testing to residents of this Commonwealth for Lyme disease, anaplasmosis, babesiosis, ehrlichiosis and Rocky Mountain spotted fever; andWHEREAS, Residents of this Commonwealth should be aware of early, disseminated and late or persistent symptoms, and that early clinical diagnosis and appropriate treatment of these tick-borne diseases and illnesses can greatly reduce the risks of continued, diverse and chronic symptoms that can affect every system and organ of the human body and often every aspect of an individual's life; andWHEREAS, As Lyme disease is endemic, the Department of Health wants to ensure that all residents of this Commonwealth have access to testing, and the Bureau of Laboratories has the capacity to perform Lyme disease testing for all uninsured or underinsured residents, but residents should also be informed that a negative Lyme disease test cannot rule out Lyme disease; andWHEREAS, "Lyme Disease and Tick-Borne Illness Awareness Month" provides an opportunity to focus on these significant and complex diseases, through dissemination of information on 20260SR0325PN1741 - 4 - 123456789101112131415161718192021222324252627282930 prevention and personal protection, raising public awareness of the causes, effects, potential severity, diagnostic challenges and treatment options of Lyme disease and underscoring important education efforts surrounding Lyme disease and other tick-borne illnesses; therefore be itRESOLVED, That the Senate designate the month of May 2026 as "Lyme Disease and Tick-Borne Illness Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the Senate continue efforts to benefit the overall health and quality of life of the residents of this Commonwealth by increasing awareness of the threat of tick bites and the potential seriousness of Lyme disease and other tick-borne illnesses.20260SR0325PN1741 - 5 - 12345678910111213
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.